Judgment of the General Court (Eighth Chamber) of 7 June 2012 —
Meda Pharma v OHIM — Nycomed (ALLERNIL)

(Joined Cases T‑492/09 and T‑147/10)

Community trade mark — Opposition proceedings — International registration designating the European Community — Word mark ALLERNIL — Application for Community word mark ALLERNIL — Earlier national word mark ALLERGODIL — Relative ground for refusal — No likelihood of confusion — Article 8(1)(b) of Regulation (EC) No 207/2009 — Grounds — Article 75 of Regulation No 207/2009

Community trade mark — Definition and acquisition of the Community trade mark — Relative grounds for refusal — Opposition by the proprietor of an earlier identical or similar mark registered for identical or similar goods or services — Likelihood of confusion with the earlier mark (Council Regulation No 207/2009, Art. 8(1)(b)) (see paras 30, 52)

Re:

Two actions brought against two decisions of the Fourth Board of Appeal of OHIM of 29 September 2009 (Cases R 1386/2007‑4 and R 697/2007‑4), relating to opposition proceedings between Meda Pharma GmbH & Co. KG and Nycomed GmbH.

Operative part

The Court:

1. Dismisses the actions;

2. Orders Meda Pharma GmbH & Co. KG to pay the costs incurred in Joined Cases T‑492/09 and T‑147/10.